Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Mark Greene Named a 2021 Mergers & Acquisitions MVP by Law360

September 14, 2021

On September 9, 2021, Cravath partner Mark I. Greene was featured as a 2021 Mergers & Acquisitions MVP by Law360, which highlighted his role guiding Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, now one of the largest generic pharmaceuticals companies in the world. The profile also pointed to Mark’s representation of AerCap in its pending $30 billion acquisition of GE Capital Aviation Services, which Law360 cited as “one of the biggest aviation deals in recent history.” In discussing the Firm’s work over the course of the last year, Mark emphasized the important partnerships with Cravath’s clients, the extraordinary collaboration that took place to meet challenges inherent in each deal and the technology that enabled the seamless transition to virtual interaction between all of the parties.

Please click here to read the full profile.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Healthcare and Life Sciences
  • Financial Services and Insurance
  • Transportation
  • Industrials and Chemicals

People

Photo
Name
Mark I. Greene
Title
Corporate
Title
Partner
Email
mgreene@cravath.com
Phone
+1-212-474-1150
vCard
Download vCard

    Education

    • J.D., 1993, University of Pennsylvania Law School
    • B.A., 1989, Cornell University

    Admitted In

    • New York

    Related News & Insights

    Deals & Cases

    July 29, 2019

    Mylan’s $50 Billion Combination with Upjohn, a Division of Pfizer

    On July 29, 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, which is structured as an all-stock, Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. Pfizer shareholders would own 57% of the combined new company, and Mylan shareholders would own 43%. Cravath is representing Mylan in connection with the transaction.

    Deals & Cases

    March 10, 2021

    AerCap’s Acquisition of GE Capital Aviation Services

    On March 10, 2021, AerCap Holdings N.V. (“AerCap”), a global leader in aircraft leasing, announced that it has entered into a definitive agreement with General Electric (“GE”) under which AerCap will acquire 100% of GE Capital Aviation Services, a GE business. Under the terms of the agreement, which has been unanimously approved by the boards of directors of AerCap and GE, GE will receive 111.5 million newly issued AerCap shares, $24 billion of cash and $1 billion of AerCap notes and/or cash. Cravath is representing AerCap in connection with the transaction.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.